Absolute Bioavailability of Intranasal Hydromorphone HCl in Patients with Perennial or Seasonal Allergic Rhinitis and with Perennial or Seasonal Allergic Rhinitis Treated with Flonase (HM0011)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/002/28/02

Funding

  • Inhalation Technology Inc: $83,884.00